Nangaku M, Takama H, Ichikawa T, Mukai K, et al. Randomized, double-blind, placebo-controlled phase 3 study of bardoxolone methyl in patients with diabetic kidney disease: design and baseline characteristics of the AYAME study. Nephrol Dial Transplant 2023;38:1204-1216.
PMID: 36002026